Cerebrolysin
Porcine brain-derived peptide mixture: neurotrophic, used in stroke and TBI recovery.
- Frequency
- once daily
- Route
- Intramuscular
- Half-life
- 3 hours
- Routes
- Intramuscular, Iv
- Status
- Approved in many countries; not FDA approved in US
Benefits
- Stroke recovery
- TBI recovery
- Cognitive improvement
- Neurotrophic support
Dosing
5-30 mL/day IM; clinical protocols typically 10-20 day courses. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Half-life
Cerebrolysin has an approximate half-life of 3 hours. Vial can display informational half-life estimates when supported data is available. These estimates are not measured blood concentrations or dosing instructions.
Storage
Room temperature, protect from light.
Reported side effects
- Dizziness
- Headache
- Injection site pain
Contraindications
- Epilepsy
- Severe renal impairment
Track Cerebrolysin with Vial
Vial logs every Cerebrolysin dose, organizes your schedule, and offers reconstitution math and supported half-life estimates. Tracking records stay on your device. A Vial Pro subscription is required. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Cerebrolysin is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.